Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 18,124 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded Jun 11 to Jun 15, 2026 · Filed Jun 15, 2026

From Jun 11 to Jun 15, 2026, Pham Quang X (Director, Chairman, CEO and Interim CFO, 10% owner) sold 18,124 Cadrenal Therapeutics, Inc. shares at an average US$3.88 for US$70,352, leaving 132,715 shares. Filed Jun 15, 2026 (Form 4).

Sold
18,124 shares
Price
US$3.88 average (US$3.58 to US$4.12)
Value
US$70,352
Holding after
132,715 shares
Trading plan
No
Role
Director, Chairman, CEO and Interim CFO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 11, 2026Common StockSale1,462US$4.12149,377Direct
Jun 12, 2026Common StockSale12,996US$3.94136,381Direct
Jun 15, 2026Common StockSale3,666US$3.58132,715Direct

Source

View original at SEC

Related